OKUR
OKUR
NASDAQ · Biotechnology

Onkure Therapeutics Inc-A

$3.79
-0.20 (-5.01%)
As of Mar 30, 10:12 PM ET ·
Financial Highlights (FY 2025)
Revenue
5.03M
Net Income
1.10M
Gross Margin
29.7%
Profit Margin
21.9%
Rev Growth
-9.3%
D/E Ratio
1.05
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 29.7% 29.7% 29.7%
Operating Margin 23.6% 26.6% 21.0%
Profit Margin 21.9% 18.0% 17.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.03M 5.08M 4.69M
Gross Profit 1.49M 1.51M 1.39M
Operating Income 1.19M 1.35M 983.2K
Net Income 1.10M 914.1K 814.2K
Gross Margin 29.7% 29.7% 29.7%
Operating Margin 23.6% 26.6% 21.0%
Profit Margin 21.9% 18.0% 17.4%
Rev Growth -9.3% +7.5% +3.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.23M 16.02M 17.11M
Total Equity 13.50M 13.01M 14.54M
D/E Ratio 1.05 1.23 1.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.45M 1.42M 1.49M
Free Cash Flow 1.19M 761.6K 738.1K